Randomization was stratified according to clinical center and interval between symptom onset and enrollment . The principal objective was to measure the effects of both treatment regimens on the incidence of stroke in the first 3 months after acute small stroke or high-risk TIA. Study Outcomes The primary efficacy outcome was a new stroke event at 90 days. Ischemic stroke was thought as an severe focal infarction of the mind or retina with one of the following: sudden onset of a fresh focal neurologic deficit, with clinical or imaging evidence of infarction lasting 24 hours or more and not attributable to a nonischemic cause ; a fresh focal neurologic deficit lasting for under 24 hours and not attributable to a nonischemic trigger but accompanied by neuroimaging proof new mind infarction; or rapid worsening of a preexisting focal neurologic deficit lasting more than 24 hours rather than attributable to a nonischemic cause, accompanied by fresh ischemic adjustments on MRI or CT of the brain and clearly unique from the index ischemic event.The agreement, that involves the participation of all 18 A*STAR study entities, provides opportunities for experts across A*STAR to embark on collaborations with Nestl-'s affiliates globally. A*STAR lately launched a joint centre with National University of Singapore – Singapore Center for Nutritional Sciences, Metabolic Illnesses, and Human Development – to advance research on nutrition, early advancement and metabolic disease. This contract may also allow Nestl – access to A*STAR's study technology and facilities. Related StoriesProper iodine diet necessary during pregnancyResearchers find significant hyperlink between breast nutrition and cancer, explore fresh preventative treatmentNutrition essential for patients dealing with severe burns Mr Lim Chuan Poh, Chairman of A*Superstar said, A*Superstar is looking towards this excellent possibility to broaden and deepen the work that we do with the world's leading nutrition and food firm to expand their R&D capabilities in Singapore.